title: Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes.
abstract: Type 2 diabetes (T2D) is characterized by reduction of beta-cell mass and dysfunctional insulin secretion. Understanding beta-cell phenotype changes as T2D progresses should help explain these abnormalities. The normal phenotype should differ from the state of overwork when beta-cells compensate for insulin resistance to keep glucose levels normal. When only mild hyperglycaemia develops, beta-cells are subjected to glucotoxicity. As hyperglycaemia becomes more severe, so does glucotoxicity. beta-Cells in all four of these situations should have separate phenotypes. When assessing phenotype with gene expression, isolated islets have artefacts resulting from the trauma of isolation and hypoxia of islet cores. An advantage comes from laser capture microdissection (LCM), which obtains beta-cell-rich tissue from pancreatic frozen sections. Valuable data can be obtained from animal models, but the real goal is human beta-cells. Our experience with LCM and gene arrays on frozen pancreatic sections from cadaver donors with T2D and controls is described. Although valuable data was obtained, we predict that the approach of taking fresh samples at the time of surgery is an even greater opportunity to markedly advance our understanding of how beta-cell phenotype evolves as T2D develops and progresses.
authors.affiliation: Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA. gordon.weir@joslin.harvard.edu
authors.forename: G C
authors.initials: GC
authors.lastname: Weir
authors.forename: L
authors.initials: L
authors.lastname: Marselli
authors.forename: P
authors.initials: P
authors.lastname: Marchetti
authors.forename: H
authors.initials: H
authors.lastname: Katsuta
authors.forename: M H
authors.initials: MH
authors.lastname: Jung
authors.forename: S
authors.initials: S
authors.lastname: Bonner-Weir
mesh_terms: D001343:Autophagy; D002102:Cadaver; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics / Q000473:pathology*; D018450:Disease Progression; D020869:Gene Expression Profiling; D006801:Humans; D006943:Hyperglycemia / Q000473:pathology* / Q000503:physiopathology; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance / Q000502:physiology*; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000473:pathology / Q000502:physiology*; D042282:Microdissection; D018384:Oxidative Stress / Q000235:genetics / Q000502:physiology*; D010179:Pancreas / Q000473:pathology*
chemical_list: D007328:Insulin